二重標的抗原結合分子 - MAB-LEGEND BIOTECH CO., LTD.

Title:

二重標的抗原結合分子

Document Type and Number:

Japanese Patent JP2022508529

Kind Code:

A

Abstract:

本発明は、二重標的抗原結合分子、二重標的抗原結合分子を含む医薬組成物、および疾患の治療における使用に関する。さらに、本発明は、二重標的抗原結合分子を生成する方法にも関する。【選択図】なし

More Like This:

JP2023515055	Inhibitory chimeric receptor architecture
JP2023528898	Anti-PDL1×EGFR bispecific antibody
JP4064812	Antibody molecules with specificity for human tumor necrosis factor α and their use

Inventors:

King Oo
趙▲じん▼
Dawn of yellow
Wang Ming
須▲じゅえ▼華
Tadashi Xu
鄒珊珊

Application Number:

JP2021542237A

Publication Date:

January 19, 2022

Filing Date:

September 29, 2018

Export Citation:

Click for automatic bibliography generation Help

Assignee:

MAB-LEGEND BIOTECH CO., LTD.

International Classes:

C12N15/13; A61K39/395; A61K47/68; A61P35/00; C07K16/30; C07K16/46; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12N15/62

Domestic Patent References:

JP2017536829A

2017-12-14

Attorney, Agent or Firm:

Sonoda/Kobayashi Patent Business Corporation

Previous Patent: Context-based recommendations for robotic process automation design

Next Patent: In-vehicle local network system